151 related articles for article (PubMed ID: 12003138)
1. An updated safety profile of moxifloxacin.
Iannini PB; Mandell LA
J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
[No Abstract] [Full Text] [Related]
2. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
Iakovlev SV; Polushkina NR; Iakovlev VP
Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
[No Abstract] [Full Text] [Related]
3. [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].
Bolkovshtein M; Lederman N; Berkovitch M
Harefuah; 2001 Nov; 140(11):1054-7. PubMed ID: 11759381
[No Abstract] [Full Text] [Related]
4. Moxifloxacin Bayer.
Barrett JF
Curr Opin Investig Drugs; 2000 Sep; 1(1):45-51. PubMed ID: 11249594
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactoid reaction caused by moxifloxacin.
Alemán AM; Quirce S; Cuesta J; Novalbos A; Sastre J
J Investig Allergol Clin Immunol; 2002; 12(1):67-8. PubMed ID: 12109537
[TBL] [Abstract][Full Text] [Related]
6. Reassuring safety profile of moxifloxacin.
Iannini PB; Kubin R; Reiter C; Tillotson G
Clin Infect Dis; 2001 Apr; 32(7):1112-4. PubMed ID: 11264046
[No Abstract] [Full Text] [Related]
7. [Moxifloxacin: results of clinical use].
Iakovlev VP; Polushkina NR
Antibiot Khimioter; 2002; 47(10):32-6. PubMed ID: 12674792
[No Abstract] [Full Text] [Related]
8. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
[TBL] [Abstract][Full Text] [Related]
9. [Moxifloxacin].
Caballero E; Cárdenas E; Gurucharri N; Rodrigo A; Honorato J
Rev Med Univ Navarra; 2000; 44(4):53-60. PubMed ID: 11341057
[No Abstract] [Full Text] [Related]
10. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
Parish LC; Witkowski JA; Routh HB
Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
[TBL] [Abstract][Full Text] [Related]
12. Profile of moxifloxacin drug interactions.
Stass H; Kubitza D
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S47-50. PubMed ID: 11249829
[TBL] [Abstract][Full Text] [Related]
13. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Iannini PB
Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
[TBL] [Abstract][Full Text] [Related]
14. Moxifloxacin-induced hypoglycemia in a non-diabetic patient.
Mandavia DR; Virpariya MM; Patel TK; Tripathi CB
Curr Drug Saf; 2012 Apr; 7(2):183-5. PubMed ID: 22873504
[TBL] [Abstract][Full Text] [Related]
15. [Playing it safe in bronchopulmonary infections].
MMW Fortschr Med; 2003 May; 145(18):57. PubMed ID: 12838909
[No Abstract] [Full Text] [Related]
16. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC
Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
[TBL] [Abstract][Full Text] [Related]
17. Improving care for patients with respiratory tract infections.
Lode H; Garau J
J Chemother; 2002 Feb; 14 Suppl 2():22-8. PubMed ID: 12003137
[TBL] [Abstract][Full Text] [Related]
18. [One year moxifloxacin. Still effective in the respiratory tract].
MMW Fortschr Med; 2001 Feb; 143(7):60. PubMed ID: 11268757
[No Abstract] [Full Text] [Related]
19. [Perspectives of use of moxifloxacin for treatment of urogenital infections].
Sidorenko SV
Antibiot Khimioter; 2002; 47(1):36-42. PubMed ID: 12077939
[No Abstract] [Full Text] [Related]
20. Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing.
Brinker A; Staffa J
Arch Intern Med; 2002 Sep; 162(17):2011-2. PubMed ID: 12230426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
